US Broker Ratings

Indivior PLC (INDV) Stock Analysis: Exploring a 23.4% Upside Potential in the Healthcare Sector

Indivior PLC (INDV), a notable player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industry, presents an intriguing opportunity for investors seeking..

Merus N.V. (MRUS) Stock Analysis: Strong Buy Ratings and Promising 44% Upside Potential

Merus N.V. (NASDAQ: MRUS) is gaining attention in the biotechnology sector with its promising pipeline of bispecific antibody therapeutics. Based in the Netherlands, this clinical-stage immuno-oncology..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: 48.55% Potential Upside Sparks Investor Interest

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (AMRX) presents a compelling case with a potential upside of 48.55%, according to recent analyst..

BGM Group Ltd. (BGM): Investor Outlook Amidst a Challenging Revenue Landscape in the Healthcare Sector

BGM Group Ltd. (BGM), a key player in the healthcare sector specializing in drug manufacturing, is navigating a complex market environment. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling the 132% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical innovator, is making waves in the biotechnology sector with its ambitious focus on neurodegenerative and lysosomal storage diseases. Despite..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Significant Upside Potential Amidst Innovative Genetic Medicines Development

Beam Therapeutics Inc. (NASDAQ: BEAM) is steadily carving out its niche in the biotechnology sector with its focus on precision genetic medicines. As the company continues..

Clover Health Investments (CLOV): Analyzing the 50% Upside Potential in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) is steadily carving a niche in the healthcare sector, focusing primarily on Medicare Advantage plans in the United States. Based..

Immunovant, Inc. (IMVT) Stock Analysis: Seizing a 145% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a dynamic player in the biotechnology sector, has been making waves with its ambitious pursuits in the field of autoimmune therapies. As..

GoodRx Holdings, Inc. (GDRX): Analyst Consensus and a 32.98% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX), a key player in the healthcare sector, operates within the Health Information Services industry. With its headquarters in Santa Monica, California,..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring the 75% Potential Upside

For investors eyeing the healthcare sector, Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) presents an intriguing opportunity, particularly with its remarkable potential upside of 75.44%. Specializing in biotechnology,..

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape with a 20% Revenue Growth

Galapagos NV (NASDAQ: GLPG), a Belgian biotechnology company focusing on oncology and immunology, is capturing investor attention with a notable 20.1% revenue growth despite facing challenges..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 70% Potential Upside with Strong Buy Ratings

In the competitive landscape of the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) stands out within the realm of medical instruments and supplies. With a market capitalization..

Zai Lab Limited (ZLAB): Analyst Ratings Signal 56% Upside Potential Amid Robust Biotech Portfolio

Investors seeking value in the healthcare sector may find Zai Lab Limited (NASDAQ: ZLAB) an intriguing prospect, as analysts project a substantial 56.84% upside potential for..

PROCEPT BioRobotics (PRCT) Stock Analysis: Exploring a 34.75% Potential Upside with Innovative Medical Devices

For investors seeking to diversify their portfolios within the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling opportunity, particularly with its robust growth potential..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Unpacking a 40% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out in the biotechnology sector with its focus on developing therapies for rare and neurological diseases. With a market..

Certara, Inc. (CERT) Stock Analysis: Potential 55.60% Upside Lures Investors

Certara, Inc. (NASDAQ: CERT) stands as a significant player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.65..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 95% Potential Upside

NovoCure Limited (NASDAQ: NVCR) stands at an intriguing juncture, presenting a unique opportunity for investors with a notable potential upside of 95.65%. As a pioneering player..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unleashing Nearly 100% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnological innovator headquartered in Durham, North Carolina, is making waves in the healthcare sector, particularly in the niche realm of..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech with 140% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) has captured the attention of investors with its promising pipeline in the biotechnology sector. With a market capitalization of $2.28 billion,..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Through Recent Market Trends

Envista Holdings Corporation (NYSE: NVST), a notable player in the healthcare sector, specializes in developing and marketing dental products across the globe. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds